Lee Pharma, IICT ink pact for synthesis of 2-Deoxy-D-Glucose
New Delhi: Hyderabad based Lee Pharma and Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG).Recently, 2-DG developed by DRDO and Dr Reddy's Laboratories has received approval for use in Covid-19 patients. It has been found to help speed up recovery and reduce...
New Delhi: Hyderabad based Lee Pharma and Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG).
Recently, 2-DG developed by DRDO and Dr Reddy's Laboratories has received approval for use in Covid-19 patients. It has been found to help speed up recovery and reduce oxygen dependence and Dr. Reddy's Laboratories has launched the drug in the form of sachets.
Lee Pharma informed that they would file the application for getting the approval from DCGI, New Delhi. Lee Pharma will manufacture and commercialize the 2-DG sachets from their formulation facility located at SEZ, Duvvada, Visakhapatnam, Andhra Pradesh, which has the accreditations, by global regulatory agencies.
Dr. Srivari Chandrashekar, Director CSIR-IICT highlighted that "There is role of CSIR in development of 2-DG, as CSIR-CCMB tested the drug on SARS-CoV-2 viral cultures. CSIR has been engaged in development of drugs for treatment of Covid-19 and has undertaken many clinical trials for repurposed drugs. Additionally, this agreement with Lee Pharma Ltd. is towards increasing affordable therapeutic options for treatment of Covid-19".
Read also: DRDO first batch of anti-COVID drug 2-DG rolled out
Raghumitra Alla, Director, Lee Pharma said, "This collaboration with CSIR-IICT for 2-DG, API is part of our broader strategy for enhancing Covid-19 treatment options. Further CSIR-IICT, Hyderabad is well-known for its high quality research & development of various new molecules and we feel proud to be associated with them."
Read also: Dr Reddys to sell DRDO anti-COVID drug at Rs 990 per sachet
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd